Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1833 | 2015 |
Development and validation of a histological index for UC MH Mosli, BG Feagan, G Zou, WJ Sandborn, G D'Haens, R Khanna, ... Gut 66 (1), 50-58, 2017 | 342 | 2017 |
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis NM Vashist, M Samaan, MH Mosli, CE Parker, JK MacDonald, SA Nelson, ... Cochrane Database of Systematic Reviews, 2018 | 245 | 2018 |
Iron deficiency anaemia: pathophysiology, assessment, practical management A Kumar, E Sharma, A Marley, MA Samaan, MJ Brookes BMJ open gastroenterology 9 (1), e000759, 2022 | 150 | 2022 |
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management MA Samaan, P Pavlidis, S Papa, N Powell, PM Irving Nature Reviews Gastroenterology & Hepatology 15 (4), 222-234, 2018 | 99 | 2018 |
A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research MA Samaan, MH Mosli, WJ Sandborn, BG Feagan, GR D'Haens, ... Inflammatory bowel diseases 20 (8), 1465-1471, 2014 | 97 | 2014 |
Reproducibility of histological assessments of disease activity in UC MH Mosli, BG Feagan, G Zou, WJ Sandborn, G D'Haens, R Khanna, ... Gut 64 (11), 1765-1773, 2015 | 83 | 2015 |
The development of a magnetic resonance imaging index for fistulising Crohn's disease MA Samaan, CAJ Puylaert, BG Levesque, GY Zou, L Stitt, SA Taylor, ... Alimentary pharmacology & therapeutics 46 (5), 516-528, 2017 | 63 | 2017 |
Small bowel video capsule endoscopy: an overview BF Mustafa, M Samaan, L Langmead, M Khasraw Expert review of gastroenterology & hepatology 7 (4), 323-329, 2013 | 62 | 2013 |
Effectiveness and safety of ustekinumab in inflammatory bowel disease: a systematic review and meta-analysis S Honap, S Meade, H Ibraheim, PM Irving, MP Jones, MA Samaan Digestive Diseases and Sciences, 1-18, 2022 | 60 | 2022 |
Reliability of measuring ileo-colonic disease activity in Crohn’s disease by magnetic resonance enterography V Jairath, I Ordas, G Zou, J Panes, J Stoker, SA Taylor, C Santillan, ... Inflammatory bowel diseases 24 (2), 440-449, 2018 | 58 | 2018 |
Safety and feasibility of using the second-generation Pillcam colon capsule to assess active colonic Crohn’s disease G D’Haens, M Löwenberg, MA Samaan, D Franchimont, C Ponsioen, ... Clinical Gastroenterology and Hepatology 13 (8), 1480-1486. e3, 2015 | 58 | 2015 |
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres MA Samaan, P Pavlidis, E Johnston, B Warner, J Digby-Bell, ... Frontline Gastroenterology 8 (3), 196-202, 2017 | 55* | 2017 |
Systematic review with meta‐analysis: placebo rates in induction and maintenance trials of Crohn's disease V Jairath, G Zou, CE Parker, JK MacDonald, MH Mosli, T AlAmeel, ... Alimentary Pharmacology & Therapeutics 45 (8), 1021-1042, 2017 | 48 | 2017 |
Incidence and severity of prepouch ileitis: a distinct disease entity or a manifestation of refractory pouchitis? MA Samaan, D de Jong, S Sahami, S Morgan, K Fragkos, ... Inflammatory Bowel Diseases 22 (3), 662-668, 2016 | 47 | 2016 |
Sa1198 agreement among experts in the endoscopic evaluation of postoperative recurrence in Crohn's disease using the Rutgeerts score K Gecse, M Lowenberg, P Bossuyt, PJ Rutgeerts, S Vermeire, L Stitt, ... Gastroenterology 5 (146), S-227, 2014 | 47 | 2014 |
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis N Powell, H Ibraheim, T Raine, RA Speight, S Papa, O Brain, M Green, ... The Lancet Gastroenterology & Hepatology 5 (7), 679-697, 2020 | 45 | 2020 |
Systematic review and meta-analysis: placebo rates in induction and maintenance trials of ulcerative colitis V Jairath, G Zou, CE Parker, JK Macdonald, MH Mosli, R Khanna, ... Journal of Crohn's and Colitis 10 (5), 607-618, 2016 | 44 | 2016 |
Tofacitinib in acute severe ulcerative colitis—a real-world tertiary center experience S Honap, P Pavlidis, S Ray, E Sharma, S Anderson, JD Sanderson, ... Inflammatory bowel diseases 26 (11), e147-e149, 2020 | 41 | 2020 |
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel S Din, A Kent, RC Pollok, S Meade, NA Kennedy, I Arnott, RM Beattie, ... Gut 69 (10), 1769-1777, 2020 | 41 | 2020 |